Open Access
Open access
Science, volume 371, issue 6530

Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape

Paul-Albert Koenig 1, 2
Hrishikesh Das 3
Hejun Liu 4
Beate M Kümmerer 5, 6
Florian N Gohr 1
Lea Marie Jenster 1
Lisa Dj Schiffelers 1
Yonas M Tesfamariam 1
Miki Uchima 1
Jennifer Deborah Wuerth 1
Karl Gatterdam 7
Natalia Ruétalo 8
Maria H. Christensen 1
Caroline I Fandrey 1
Sabine Normann 1
Jan Mp Tödtmann 2
Steffen Pritzl 2
Leo Hanke 9
Jannik Boos 10
Meng Yuan 4
Xue-Yong Zhu 4
J. Schmid-Burgk 11
Hiroki Kato 12
Michael Schindler 8
I. H. Wilson 4, 13
Matthias Geyer 7
Kerstin U. Ludwig 10
B. Martin Hallberg 3, 14
Nicholas Wu 15, 16, 17
Florian I. Schmidt 1, 2
14
 
Centre for Structural Systems Biology (CSSB) and Karolinska Institutet VR-RÃ…C, Notkestrasse 85, 22607 Hamburg, Germany.
Publication typeJournal Article
Publication date2021-02-12
Journal: Science
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor56.9
ISSN00368075, 10959203
Multidisciplinary
Abstract
A double punch against SARS-CoV-2

Monoclonal antibodies are an important weapon in the battle against COVID-19. However, these large proteins are difficult to produce in the needed quantities and at low cost. Attention has turned to nanobodies, which are aptly named, single-domain antibodies that are easier to produce and have the potential to be administered by inhalation. Koenig et al. describe four nanobodies that bind to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein and prevent infection of cells (see the Perspective by Saelens and Schepens). Structures show that the nanobodies target two distinct epitopes on the SARS-CoV-2 spike protein. Multivalent nanobodies neutralize virus much more potently than single nanobodies, and multivalent nanobodies that bind two epitopes prevent the emergence of viral escape mutants.

Science , this issue p. eabe6230 ; see also p. 681

Top-30

Citations by journals

2
4
6
8
10
12
Frontiers in Immunology
12 publications, 3.79%
Nature Communications
11 publications, 3.47%
International Journal of Molecular Sciences
7 publications, 2.21%
Viruses
7 publications, 2.21%
Scientific Reports
5 publications, 1.58%
mAbs
5 publications, 1.58%
Communications Biology
4 publications, 1.26%
International Journal of Biological Macromolecules
4 publications, 1.26%
iScience
4 publications, 1.26%
Proceedings of the National Academy of Sciences of the United States of America
4 publications, 1.26%
Cells
3 publications, 0.95%
Frontiers in Molecular Biosciences
3 publications, 0.95%
Signal Transduction and Targeted Therapy
3 publications, 0.95%
Cell Reports
3 publications, 0.95%
Antiviral Research
3 publications, 0.95%
Advanced Science
3 publications, 0.95%
Journal of the American Chemical Society
3 publications, 0.95%
EMBO Reports
3 publications, 0.95%
PLoS Pathogens
3 publications, 0.95%
Microorganisms
2 publications, 0.63%
Vaccines
2 publications, 0.63%
Frontiers in Microbiology
2 publications, 0.63%
Nature
2 publications, 0.63%
Journal of Nanobiotechnology
2 publications, 0.63%
Journal of Biological Chemistry
2 publications, 0.63%
Nano Today
2 publications, 0.63%
Virologica Sinica
2 publications, 0.63%
Current Opinion in Virology
2 publications, 0.63%
Structure
2 publications, 0.63%
2
4
6
8
10
12

Citations by publishers

10
20
30
40
50
60
70
Cold Spring Harbor Laboratory
62 publications, 19.56%
Elsevier
55 publications, 17.35%
Springer Nature
51 publications, 16.09%
Multidisciplinary Digital Publishing Institute (MDPI)
26 publications, 8.2%
Frontiers Media S.A.
21 publications, 6.62%
Wiley
19 publications, 5.99%
American Chemical Society (ACS)
18 publications, 5.68%
EMBO press
6 publications, 1.89%
Public Library of Science (PLoS)
6 publications, 1.89%
Taylor & Francis
6 publications, 1.89%
Oxford University Press
6 publications, 1.89%
American Association for the Advancement of Science (AAAS)
6 publications, 1.89%
American Society for Microbiology
5 publications, 1.58%
Proceedings of the National Academy of Sciences (PNAS)
4 publications, 1.26%
Royal Society of Chemistry (RSC)
3 publications, 0.95%
American Society for Biochemistry and Molecular Biology
2 publications, 0.63%
KeAi Communications Co.
2 publications, 0.63%
Microbiology Society
1 publication, 0.32%
NEJM Group
1 publication, 0.32%
Portland Press
1 publication, 0.32%
Dove Medical Press
1 publication, 0.32%
Walter de Gruyter
1 publication, 0.32%
Cambridge University Press
1 publication, 0.32%
Rockefeller University Press
1 publication, 0.32%
American Institute of Mathematical Sciences (AIMS)
1 publication, 0.32%
eLife Sciences Publications
1 publication, 0.32%
Scientific Scholar
1 publication, 0.32%
Bentham Science
1 publication, 0.32%
Spandidos Publications
1 publication, 0.32%
10
20
30
40
50
60
70
  • We do not take into account publications without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Koenig P. et al. Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape // Science. 2021. Vol. 371. No. 6530.
GOST all authors (up to 50) Copy
Koenig P., Das H., Liu H., Kümmerer B. M., Gohr F. N., Jenster L. M., Schiffelers L. D., Tesfamariam Y. M., Uchima M., Wuerth J. D., Gatterdam K., Ruétalo N., Christensen M. H., Fandrey C. I., Normann S., Tödtmann J. M., Pritzl S., Hanke L., Boos J., Yuan M., Zhu X., Schmid-Burgk J., Kato H., Schindler M., Wilson I. H., Geyer M., Ludwig K. U., Hallberg B. M., Wu N., Schmidt F. I. Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape // Science. 2021. Vol. 371. No. 6530.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1126/science.abe6230
UR - https://doi.org/10.1126/science.abe6230
TI - Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape
T2 - Science
AU - Koenig, Paul-Albert
AU - Das, Hrishikesh
AU - Liu, Hejun
AU - Kümmerer, Beate M
AU - Gohr, Florian N
AU - Jenster, Lea Marie
AU - Schiffelers, Lisa Dj
AU - Tesfamariam, Yonas M
AU - Uchima, Miki
AU - Wuerth, Jennifer Deborah
AU - Gatterdam, Karl
AU - Ruétalo, Natalia
AU - Christensen, Maria H.
AU - Fandrey, Caroline I
AU - Normann, Sabine
AU - Tödtmann, Jan Mp
AU - Pritzl, Steffen
AU - Hanke, Leo
AU - Boos, Jannik
AU - Yuan, Meng
AU - Zhu, Xue-Yong
AU - Schmid-Burgk, J.
AU - Kato, Hiroki
AU - Schindler, Michael
AU - Wilson, I. H.
AU - Geyer, Matthias
AU - Ludwig, Kerstin U.
AU - Hallberg, B. Martin
AU - Wu, Nicholas
AU - Schmidt, Florian I.
PY - 2021
DA - 2021/02/12 00:00:00
PB - American Association for the Advancement of Science (AAAS)
IS - 6530
VL - 371
SN - 0036-8075
SN - 1095-9203
ER -
BibTex
Cite this
BibTex Copy
@article{2021_Koenig,
author = {Paul-Albert Koenig and Hrishikesh Das and Hejun Liu and Beate M Kümmerer and Florian N Gohr and Lea Marie Jenster and Lisa Dj Schiffelers and Yonas M Tesfamariam and Miki Uchima and Jennifer Deborah Wuerth and Karl Gatterdam and Natalia Ruétalo and Maria H. Christensen and Caroline I Fandrey and Sabine Normann and Jan Mp Tödtmann and Steffen Pritzl and Leo Hanke and Jannik Boos and Meng Yuan and Xue-Yong Zhu and J. Schmid-Burgk and Hiroki Kato and Michael Schindler and I. H. Wilson and Matthias Geyer and Kerstin U. Ludwig and B. Martin Hallberg and Nicholas Wu and Florian I. Schmidt},
title = {Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape},
journal = {Science},
year = {2021},
volume = {371},
publisher = {American Association for the Advancement of Science (AAAS)},
month = {feb},
url = {https://doi.org/10.1126/science.abe6230},
number = {6530},
doi = {10.1126/science.abe6230}
}
Found error?